#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Autoimmune disorder Infertility female Alternating hemiplegia of childhood Canavan disease Neuroendocrine carcinoma metastatic Ectonucleotide pyrophosphatase/phosphodiesterase 1 deficiency Ischaemic stroke Hyperinsulinism B-cell small lymphocytic lymphoma Polyneuropathy KBG syndrome Hyperinsulinaemic hypoglycaemia Ataxia telangiectasia Hereditary haemorrhagic telangiectasia Transitional cell cancer of the renal pelvis and ureter More trials…

    Learn about Rare Diseases

    Gaucher’s disease type III – Diagnostics Focal segmental glomerulosclerosis – Basic Information Chordoma – Diagnostics Pleural mesothelioma malignant – Trials in Disease Idiopathic inflammatory myopathy – Trials in Disease Marginal zone lymphoma – Life with Disease Idiopathic inflammatory myopathy – Diagnostics Prader-Willi syndrome – Treatment Brain stem glioma – Diagnostics Ehlers-Danlos syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Promethazine Hydrochloride Ubamatamab Tertomotide Acp-017 Zasocitinib Vepdegestrant Nnc0194-0499 Gelatin CLESROVIMAB Losmapimod Iph5201 Bi 3032950 Oxymetazoline Hydrochloride Riboflavin Bp Anhydrous Benzoyl Peroxide Sodium Hydrogen Carbonate Eye103 Venlafaxine Tetrahydrouridine Ketamine More therapies…

    Learn about Your Condition

    Axial spondyloarthritis Bladder cancer stage II Genitourinary tract neoplasm Cardiac arrest Perinatal depression Multiple system atrophy Lymphatic malformation Vascular malformation Papillary thyroid cancer Arrhythmia supraventricular Caesarean section Carpal tunnel syndrome Eclampsia Vascular graft thrombosis Endocarditis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hyperinsulinaemic hypoglycaemia

  • Study on Ersodetug for Patients with Uncontrolled Low Blood Sugar Due to Tumor-Related High Insulin Levels

    Recruiting

    3 1 1
    Investigated Drugs:
    • Anti-(Insulin Receptor) Human Monoclonal Antibody
    France The Netherlands

  • Study on the Effects of Pasireotide in Patients with Low Blood Sugar After Bariatric Surgery

    Not recruiting

    2 1
    Investigated Drugs:
    • Pasireotide Diaspartate
    • Placebo
    Belgium France Italy Spain

  • Study on RZ358 for Treating Congenital Hyperinsulinism in Patients

    Not recruiting

    3 1
    Investigated Diseases:
    • Hyperinsulinaemic hypoglycaemia
    • Hyperinsulinism
    Investigated Drugs:
    • Anti-(Insulin Receptor) Human Monoclonal Antibody
    Bulgaria Denmark France Germany Greece Spain

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!